We rarely worry about marijuana. So why is it still a Schedule I drug?
A mainland-based laboratory is expanding to Hawaiʻi with a facility on Maui that will offer cannabis testing as the state’s Medical Marijuana Dispensary Program gets underway.
We rarely worry about marijuana. So why is it still a Schedule I drug?
A mainland-based laboratory is expanding to Hawaiʻi with a facility on Maui that will offer cannabis testing as the state’s Medical Marijuana Dispensary Program gets underway.
With legalization of marijuana increasing across the United States, there is more focus than ever on identifying the risks and benefits of the drug. A new study provides further insight, after finding men experience greater pain relief with marijuana use than women.
Because the topic still is not usually covered in medical school, seasoned doctors, as well as younger ones, often consider themselves ill-equipped.
The look inside the state's secretive program comes as the struggling medical marijuana industry in Illinois is poised to grow.
Severe pain drove this average Minnesotan to seek the comforts of medical cannabis. Here's how things worked out for her.
Glaucoma is the name for a group of eye diseases that affect the eyes and vision.
For the first time in Central Florida, a medical marijuana product has been delivered to a patient.
With nearly 3,000 caregivers, competition has ramped up as operations get larger and businesses look for a niche.
After months of delay, state officials granted Maryland's first preliminary medical marijuana licenses.
Copyright 2019 - 2024. WeedWorthy.com is a news division of MjLink.com, Inc.. All rights reserved. WeedWorthy
To contact the following departments, dial 1-844-420-4208 - Sales: Ext. #2 - Support: Ext. #3 - Investor Relations: Ext. #6
By using this website, you agree and understand that, by law: You MUST be at least 21 years of age to view any content on this website. To view the complete Terms of Use and Privacy Policy for this website, Click Here!